HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$84.89
+1.30 (+1.56%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.48%
1Y
+36.70%
YTD
+20.74%
Open$84.15
Previous Close$83.59
Day High$85.04
Day Low$82.60
52W High$84.44
52W Low$58.53
Volume—
Avg Volume1.68M
Market Cap9.73B
P/E Ratio27.90
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$71.23
Above
SMA 200
$65.75
Above
RSI (14)
47.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
16 analysts
Price Target
-75.2% upside
Current
$84.89
$84.89
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.33B | 1.04B | 1.30B |
| Net Income | 301.59M | 211.43M | -74,995,325 |
| Profit Margin | 22.7% | 21.6% | -5.8% |
| EBITDA | 514.12M | 380.45M | -91,476,031 |
| Free Cash Flow | — | — | -86,399,966 |
| Rev Growth | +28.4% | +28.4% | +13.4% |
| Debt/Equity | 43.89 | 43.89 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |